Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Gamida Cell Ltd (GMDA)

  • Technical Exchange News
  • April 08, 2024, 01:06 UTC
  • 30
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Gamida Cell Ltd. - Ordinary Shares. New value: Gamida Cell Ltd. - Ordinary Shares.

Comment Full text

NGM Biopharmaceuticals Inc (NGM)

  • Technical Exchange News
  • April 08, 2024, 01:06 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: NGM Biopharmaceuticals, Inc. - Common Stock.

Comment Full text

X4 Pharmaceuticals Inc. (XFOR)

  • Technical Exchange News
  • April 06, 2024, 02:00 UTC
  • 35
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Gamida Cell Ltd (GMDA)

  • Technical Exchange News
  • April 06, 2024, 02:00 UTC
  • 33
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

X4 Pharmaceuticals Inc. (XFOR)

  • Technical Exchange News
  • April 05, 2024, 18:48 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Gamida Cell Ltd (GMDA)

  • Technical Exchange News
  • April 05, 2024, 18:47 UTC
  • 34
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • April 05, 2024, 01:49 UTC
  • 34
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCC)

  • Technical Exchange News
  • April 05, 2024, 01:49 UTC
  • 33
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCC)

  • Technical Exchange News
  • April 04, 2024, 18:47 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • April 04, 2024, 18:47 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 732
  • 733
  • 734
  • 735
  • 736
  • Next

Search

News categories

  • Technical Exchange News(12002)
  • Event(5170)
  • SEC News(249095)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(149702)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin